Fig. 3From: The safety and efficacy of nicotine replacement therapy in the intensive care unit: a randomised controlled pilot studyPatients alive without delirium and without sedation or coma comparing nicotine replacement therapy and placebo group. Data presented as the percentage of time patients were alive without delirium and without sedation or coma (RASS ≥ − 3). NRT nicotine replacement therapyBack to article page